Latest filing published 24 Jul 2026 for VYNE Therapeutics Inc., €12k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Iain Stuart is a declared insider of Yarrow Bioscience, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 30 June 2021 and 23 July 2026, the trades on record add up to 24 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 24 July 2026 came the latest disclosure, a share grant for €12k in Yarrow Bioscience, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations